High-dose chemotherapy for breast cancer

This publication has 16 references indexed in Scilit:

• Dose and Dose Intensity of Adjuvant Chemotherapy for Stage II, Node-Positive Breast Carcinoma
  New England Journal of Medicine, 1994
• High-dose therapy: here to stay or just visiting?
  Journal of Clinical Oncology, 1994
• Detection and viability of tumor cells in peripheral blood stem cell collections from breast cancer patients using immunocytochemical and clonogenic assay techniques [see comments]
  Blood, 1993
• High-dose chemotherapy and autologous bone marrow support as consolidation after standard-dose adjuvant therapy for high-risk primary breast cancer.
  Journal of Clinical Oncology, 1993
• Systemic treatment of early breast cancer by hormonal, cytotoxic, or immune therapy
  The Lancet, 1992
• Dose-intensive treatment of breast cancer supported by granulocyte-macrophage colony-stimulating factor (GM-CSF)
  Breast Cancer Research and Treatment, 1991
• “Classical” CMF versus a 3-weekly intravenous CMF schedule in postmenopausal patients with advanced breast cancer: An EORTC Breast Cancer Co-operative Group Phase III Trial (10808)
  European Journal of Cancer and Clinical Oncology, 1991
• Combination chemotherapy and high-dose cyclophosphamide intensification for poor prognosis breast cancer. A southwest oncology group study
  Cancer, 1989
• High-dose combination alkylating agents with bone marrow support as initial treatment for metastatic breast cancer.
  Journal of Clinical Oncology, 1988
• Evaluation of high-dose versus standard FAC chemotherapy for advanced breast cancer in protected environment units: a prospective randomized study.
  Journal of Clinical Oncology, 1987